About the Meeting
Antibiotic Resistance (‘ABR’) has featured heavily in the news, and has been a particular concern of the nation’s Chief Medical Officer. ABR has the potential to wipe out the future mortality/longevity improvements we might otherwise reasonably expect from general medical/lifestyle advances. In January 2017 the IFoA set up a working party to model the likely impact of ABR. In this session, members of the working party will present their findings (including plausible future scenarios and mortality/morbidity impacts), and describe the model produced by the working party (with associated UK parameterisation).
Speakers:
- Nicola Oliver, Mortality and Longevity Consultant, Medical Intelligence (UK) Ltd.
- Ross Hamilton, Pensions Consultant, Willis Towers Watson
Tickets available here
Related Events
(VIRTUAL) IFRS 17 for Reinsurance: How to measure and explain performance
This presentation aims to explain how the reinsurance contracts are treated under IFRS 17.
Zoom (Virtual event)
(VIRTUAL) CMI Update - Mortality improvements in light of the pandemic
A CMI update on mortality in light of the pandemic.
Zoom (Virtual event)
(VIRTUAL) Data Science - optimising the actuarial toolkit
A data science talk focused on the toolkit used in the actuarial departments.